DYNE THERAPEUTICS INC (DYN) Stock Analyst Ratings
NASDAQ:DYN - Nasdaq - US26818M1080 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 86% to DYN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 52.58. This target is 324% above the current price.
DYN was analyzed by 16 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about DYN.
In the previous month the buy percentage consensus was at a similar level.
DYN was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-02-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-24 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-01-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-13 | Baird | Initiate | Outperform |
| 2024-11-26 | RBC Capital | Initiate | Outperform |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-24 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-09-23 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-08-16 | Stifel | Maintains | Buy -> Buy |
| 2024-08-15 | Guggenheim | Maintains | Buy -> Buy |
| 2024-08-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-21 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-20 | Jefferies | Maintains | Buy -> Buy |
| 2024-05-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-06 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-30 | Morgan Stanley | Initiate | Overweight |